跳至主要内容
临床试验/JPRN-UMIN000006684
JPRN-UMIN000006684已完成4 期

Outcome in Hemodialysis of Promus stent - OUCH-PRO

Coronary Intervention Trial and Evaluation group0 个研究点目标入组 120 人开始时间: 2011年11月8日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
21years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • CPA Cardiogenic shock Emergent PCI STEMI Intolerance with antiplatelet therapy Planned PCI for other lesions in 6 months Restenosis after DES Severe valvular heart disease Critical limb ischemia CTO No indication for PCI

研究者

发起方
Coronary Intervention Trial and Evaluation group

相似试验

尚未招募
不适用
Clinical Outcome of Peritoneal Versus Hemodialysis Diabetic Patients: A Single-Center Ambispective Cohort Study (CO_PHD)Diabetic kidney disease patients receiving peritoneal dialysis and hemodialysis treatment
ITMCTR1900002418Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
已完成
4 期
OUtcome of Cypher stent with patients on Hemodialysis registryHemodialysis patients who undergo elective percutaneous coronary intervention (PCI) using sirolimus eluting stents
JPRN-UMIN000001155CITE group120
尚未招募
2 期
Stenting of Haemodialysis Acces Trialoutflow-stenosisstentgraft1000318410003216
NL-OMON31017W. L. Gore & Associates Inc, U.S.A.20
已完成
4 期
Does a continuous low-dose antibiotic treatment lower the rates of urinary tract infections and stent related symptoms in patients with ureteral stents compared to a periinterventionel prophylaxis only?rinary tract infection (UTI)Ureteral stent related symptoms (SRS)Urinary tract infection (UTI)Renal and Urogenital - Other renal and urogenital disorders
ACTRN12612000002886Department of Urology, University Hospital Bern88
已完成
不适用
PrasugrEl moNotherapy after DrUg eLUting stent deployMent as a Management Of patients who are uNsuitable for lOng-term dual antiplatelet therapyPatient who underwent placement of a drug elution stent by percutaneous coronary intervention, have a high bleeding risk, and are considered to have a medical difficulty in receiving long-term administration of Aspirin
JPRN-UMIN000028023Toho University Ohashi Medical Center1,222